209 related articles for article (PubMed ID: 12145104)
1. Two tyrosine residues in the first transmembrane helix of the human vasoactive intestinal peptide receptors play a role in supporting the active conformation.
Perret J; Vertongen P; Solano RM; Langer I; Cnudde J; Robberecht P; Waelbroeck M
Br J Pharmacol; 2002 Aug; 136(7):1042-8. PubMed ID: 12145104
[TBL] [Abstract][Full Text] [Related]
2. Mutational analysis of the human vasoactive intestinal peptide receptor subtype VPAC(2): role of basic residues in the second transmembrane helix.
Vertongen P; Solano RM; Perret J; Langer I; Robberecht P; Waelbroeck M
Br J Pharmacol; 2001 Aug; 133(8):1249-54. PubMed ID: 11498510
[TBL] [Abstract][Full Text] [Related]
3. Ac His1 [D-Phe2, K15, R16, L27] VIP (3-7)/GRF (8-27)--a VPAC1 receptor antagonist--is an inverse agonist on two constitutively active truncated VPAC1 receptors.
Vertongen P; Langlet C; Langer I; Gaspard N; Robberecht P
Peptides; 2004 Nov; 25(11):1943-9. PubMed ID: 15501526
[TBL] [Abstract][Full Text] [Related]
4. Evidence for a direct interaction between the Thr11 residue of vasoactive intestinal polypeptide and Tyr184 located in the first extracellular loop of the VPAC2 receptor.
Nachtergael I; Vertongen P; Langer I; Perret J; Robberecht P; Waelbroeck M
Biochem J; 2003 Mar; 370(Pt 3):1003-9. PubMed ID: 12475394
[TBL] [Abstract][Full Text] [Related]
5. Different vasoactive intestinal polypeptide receptor domains are involved in the selective recognition of two VPAC(2)-selective ligands.
Juarranz MG; Van Rampelbergh J; Gourlet P; De Neef P; Cnudde J; Robberecht P; Waelbroeck M
Mol Pharmacol; 1999 Dec; 56(6):1280-7. PubMed ID: 10570056
[TBL] [Abstract][Full Text] [Related]
6. Vasoactive intestinal polypeptide receptor VPAC(1) subtype is predominant in rat prostate membranes.
Juarranz MG; De Neef P; Robberecht P
Prostate; 1999 Sep; 41(1):1-6. PubMed ID: 10440869
[TBL] [Abstract][Full Text] [Related]
7. Characterization of a novel VPAC(1) selective agonist and identification of the receptor domains implicated in the carboxyl-terminal peptide recognition.
Van Rampelbergh J; Juarranz MG; Perret J; Bondue A; Solano RM; Delporte C; De Neef P; Robberecht P; Waelbroeck M
Br J Pharmacol; 2000 Jun; 130(4):819-26. PubMed ID: 10864888
[TBL] [Abstract][Full Text] [Related]
8. Elucidation of the vasoactive intestinal peptide pharmacophore for VPAC(2) receptors in human and rat and comparison to the pharmacophore for VPAC(1) receptors.
Igarashi H; Ito T; Pradhan TK; Mantey SA; Hou W; Coy DH; Jensen RT
J Pharmacol Exp Ther; 2002 Nov; 303(2):445-60. PubMed ID: 12388623
[TBL] [Abstract][Full Text] [Related]
9. Asn229 in the third helix of VPAC1 receptor is essential for receptor activation but not for receptor phosphorylation and internalization: comparison with Asn216 in VPAC2 receptor.
Nachtergael I; Gaspard N; Langlet C; Robberecht P; Langer I
Cell Signal; 2006 Dec; 18(12):2121-30. PubMed ID: 16650965
[TBL] [Abstract][Full Text] [Related]
10. Tryptophan 67 in the human VPAC(1) receptor: crucial role for VIP binding.
Nicole P; Maoret JJ; Couvineau A; Momany FA; Laburthe M
Biochem Biophys Res Commun; 2000 Sep; 276(2):654-9. PubMed ID: 11027527
[TBL] [Abstract][Full Text] [Related]
11. Effect of inactivating mutations on phosphorylation and internalization of the human VPAC2 receptor.
Langer I; Langlet C; Robberecht P
J Mol Endocrinol; 2005 Apr; 34(2):405-14. PubMed ID: 15821106
[TBL] [Abstract][Full Text] [Related]
12. Two basic residues of the h-VPAC1 receptor second transmembrane helix are essential for ligand binding and signal transduction.
Solano RM; Langer I; Perret J; Vertongen P; Juarranz MG; Robberecht P; Waelbroeck M
J Biol Chem; 2001 Jan; 276(2):1084-8. PubMed ID: 11013258
[TBL] [Abstract][Full Text] [Related]
13. Creation of a selective antagonist and agonist of the rat VPAC(1) receptor using a combinatorial approach with vasoactive intestinal peptide 6-23 as template.
Tams JW; Jorgensen RM; Holm A; Fahrenkrug J
Mol Pharmacol; 2000 Nov; 58(5):1035-41. PubMed ID: 11040051
[TBL] [Abstract][Full Text] [Related]
14. Identification of key residues for interaction of vasoactive intestinal peptide with human VPAC1 and VPAC2 receptors and development of a highly selective VPAC1 receptor agonist. Alanine scanning and molecular modeling of the peptide.
Nicole P; Lins L; Rouyer-Fessard C; Drouot C; Fulcrand P; Thomas A; Couvineau A; Martinez J; Brasseur R; Laburthe M
J Biol Chem; 2000 Aug; 275(31):24003-12. PubMed ID: 10801840
[TBL] [Abstract][Full Text] [Related]
15. A small sequence in the third intracellular loop of the VPAC(1) receptor is responsible for its efficient coupling to the calcium effector.
Langer I; Vertongen P; Perret J; Waelbroeck M; Robberecht P
Mol Endocrinol; 2002 May; 16(5):1089-96. PubMed ID: 11981043
[TBL] [Abstract][Full Text] [Related]
16. VPAC2 receptors mediate vasoactive intestinal peptide-induced neuroprotection against neonatal excitotoxic brain lesions in mice.
Rangon CM; Goursaud S; Medja F; Lelièvre V; Mounien L; Husson I; Brabet P; Jégou S; Janet T; Gressens P
J Pharmacol Exp Ther; 2005 Aug; 314(2):745-52. PubMed ID: 15872042
[TBL] [Abstract][Full Text] [Related]
17. Characterization and expression of different pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide receptors in rat ovarian follicles.
Vaccari S; Latini S; Barberi M; Teti A; Stefanini M; Canipari R
J Endocrinol; 2006 Oct; 191(1):287-99. PubMed ID: 17065411
[TBL] [Abstract][Full Text] [Related]
18. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in the goose cerebral cortex.
Zawilska JB; Niewiadomski P; Nowak JZ
Pol J Pharmacol; 2004; 56(2):203-11. PubMed ID: 15156071
[TBL] [Abstract][Full Text] [Related]
19. VIP activates G(s) and G(i3) in rat alveolar macrophages and G(s) in HEK293 cells transfected with the human VPAC(1) receptor.
Shreeve SM; Sreedharan SP; Hacker MP; Gannon DE; Morgan MJ
Biochem Biophys Res Commun; 2000 Jun; 272(3):922-8. PubMed ID: 10860852
[TBL] [Abstract][Full Text] [Related]
20. Development of selective agonists and antagonists for the human vasoactive intestinal polypeptide VPAC(2) receptor.
Moreno D; Gourlet P; De Neef P; Cnudde J; Waelbroeck M; Robberecht P
Peptides; 2000 Oct; 21(10):1543-9. PubMed ID: 11068102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
